BRTX · BioRestorative Therapies, Inc.
Substantial doubt about the company's ability to continue as a going concern.
“Based on these conditions, we believe we do not have sufficient cash for at least twelve months after the issuance date of the financial statements included in this Quarterly Report which raises substantial doubt about our ability to continue as a going concern.”View the 10-Q filed May 14, 2026
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-07-14 | Brown Steven Collier |
Director |
Other↑
|
No Securities Owned
|
0 |
| 2026-06-10 | Dhaliwal Jatinder |
Director |
Other↑
|
No Securities Owned
|
0 |
| 2026-06-10 | Grasso Mika |
Director |
Other↑
|
No Securities Owned
|
0 |
| 2026-06-10 | Field Katharyn |
Director, Director and Executive Officer |
Other↑
|
No Securities Owned
|
0 |
| 2025-10-06 | ALSTODT LANCE |
Director, President, CEO, COB, 10% Owner |
Award↑
|
Common Stock
|
15,625 |
| 2025-10-06 | Silva Francisco |
Director, VP of Research and Development |
Award↑
|
Warrant
|
11,719 |
| 2025-10-06 | Silva Francisco |
Director, VP of Research and Development |
Award↑
|
Comon Stock
|
11,719 |
| 2025-10-06 | ALSTODT LANCE |
Director, President, CEO, COB, 10% Owner |
Award↑
|
Warrant
|
11,719 |
| 2025-02-14 | Rosa David A |
Director, CEO and President |
Award↑
Filing footnotes — Stock Option (Direct)
The option vests and becomes exercisable in twelve nearly equal monthly installments of 4,386 shares beginning on March 14, 2025 and continuing every month thereafter until fully vested. |
Stock Option
|
52,632 |
| 2025-02-14 | Kristal Robert Eugene |
Chief Financial Officer |
Award↑
Filing footnotes — Stock Option (Direct)
The option vests and becomes exercisable to the extent of 83,246 shares on February 14, 2025 with the remaining 83,246 shares vesting in eight nearly-equal quarterly installments beginning on February 14, 2026 and continuing every three months thereafter until fully vested. |
Stock Option
|
166,492 |
| 2025-02-14 | Kukekov Nickolay V. |
Director |
Award↑
Filing footnotes — Stock Option (Direct)
The option vests and becomes exercisable in twelve nearly equal monthly installments of 4,386 shares beginning on March 14, 2025 and continuing each month thereafter until fully vested. |
Stock Option
|
52,632 |
| 2025-02-14 | Silva Francisco |
Director, VP of Research and Development |
Award↑
Filing footnotes — Stock Option (Direct)
The option vests and becomes exercisable to the extent of 384,490 shares on February 14, 2025 and 384,489 shares in eight nearly equal quarterly installments beginning February 14, 2026 and continuing every three months thereafter until fully vested. |
Stock Option
|
768,979 |
| 2025-02-14 | Williams Patrick F. |
Chief Financial Officer |
Award↑
Filing footnotes — Stock Option (Direct)
The option vests and becomes exercisable in twelve nearly equal monthly installments of 4,386 shares beginning on March 14, 2025 and continuing every month thereafter until fully vested. |
Stock Option
|
52,632 |
| 2025-02-14 | ALSTODT LANCE |
Director, President, CEO, COB, 10% Owner |
Award↑
Filing footnotes — Stock Option (Direct)
The options vests and becomes exercisable to the extent of 395,943 shares on February 14, 2025 and 395,942 shares in eight nearly equal quarterly installments beginning February 14, 2026 and continuing every three months thereafter until fully vested. |
Stock Option
|
791,885 |
| 2024-10-28 | Broadrick Dale |
10% Owner |
Sell↓
|
Common Stock
|
1,112 |
| 2024-04-09 | Silva Francisco |
Director, VP of Research and Development |
Buy↑
|
Common Stock
|
6,600 |
| 2024-04-08 | Silva Francisco |
Director, VP of Research and Development |
Buy↑
|
Common Stock
|
476 |
| 2024-04-08 | Silva Francisco |
Director, VP of Research and Development |
Buy↑
|
Common Stock
|
1,232 |
| 2024-03-18 | ALSTODT LANCE |
Director, President, CEO, COB, 10% Owner |
Tax↓
Filing footnotes — Common Stock (Direct)
Shares were withheld from vested stock grant to pay the associated withholding taxes. |
Common Stock
|
17,633 |
| 2024-03-18 | Silva Francisco |
Director, VP of Research and Development |
Tax↓
Filing footnotes — Common Stock (Direct)
Shares were withheld from vested stock grant to pay the associated withholding taxes. |
Common Stock
|
17,193 |
| 2024-02-13 | Kukekov Nickolay V. |
Director |
Award↑
Filing footnotes — Stock Option (Direct)
The option vests and becomes exercisable in twelve nearly equal monthly installments of 6,637 shares beginning on March 13, 2024 and continuing each month thereafter until fully vested. |
Stock Option
|
79,646 |
| 2024-02-13 | Paccasassi Robert |
VP, QA and Reg Compliance |
Award↑
Filing footnotes — Stock Option (Direct)
The option vests and becomes exercisable to the extent of 109,649 shares on February 13, 2024 with the remaining 109,649 shares vesting in eight nearly-equal quarterly installments beginning on February 13, 2025 and continuing every three months thereafter until fully vested. |
Stock Option
|
219,298 |
| 2024-02-13 | ALSTODT LANCE |
Director, President, CEO, COB, 10% Owner |
Award↑
Filing footnotes — Stock Option (Direct)
The option vests and becomes exercisable to the extent of 219,298 shares on February 13, 2024 and 219,298 shares in eight nearly equal quarterly installments beginning February 13, 2025 and continuing every three months thereafter until fully vested. |
Stock Option
|
438,596 |
| 2024-02-13 | Williams Patrick F. |
Chief Financial Officer |
Award↑
Filing footnotes — Stock Option (Direct)
The option vests and becomes exercisable in twelve nearly equal monthly installments of 6,637 shares beginning on March 13, 2024 and continuing every month thereafter until fully vested. |
Stock Option
|
79,646 |
| 2024-02-13 | Silva Francisco |
Director, VP of Research and Development |
Award↑
Filing footnotes — Stock Option (Direct)
The option vests and becomes exercisable to the extent of 197,369 shares on February 13, 2024 and 197,368 shares in eight nearly equal quarterly installments beginning February 13, 2025 and continuing every three months thereafter until fully vested. |
Stock Option
|
394,737 |
| 2024-02-13 | Kristal Robert Eugene |
Chief Financial Officer |
Award↑
Filing footnotes — Stock Option (Direct)
The option vests and becomes exercisable to the extent of 131,579 shares on February 13, 2024 with the remaining 131,579 shares vesting in eight nearly-equal quarterly installments beginning on February 13, 2025 and continuing every three months thereafter until fully vested. |
Stock Option
|
263,158 |
| 2024-02-13 | Rosa David A |
Director, CEO and President |
Award↑
Filing footnotes — Stock Option (Direct)
The option vests and becomes exercisable in twelve nearly equal monthly installments of 6,637 shares beginning on March 13, 2024 and continuing every month thereafter until fully vested. |
Stock Option
|
79,646 |
| 2024-02-09 | Broadrick Dale |
10% Owner |
Buy↑
Filing footnotes — Common Stock (Indirect)
Owned by Fleetco, Inc. of which the reporting person is a 93% shareholder. |
Common Stock
(I)
|
86,041 |
| 2024-02-08 | Broadrick Dale |
10% Owner |
Buy↑
Filing footnotes — Common Stock (Indirect)
Owned by Fleetco, Inc. of which the reporting person is a 93% shareholder. |
Common Stock
(I)
|
73,959 |
| 2024-02-08 | Broadrick Dale |
10% Owner |
Buy↑
|
Common Stock
|
83,626 |
| 2024-02-07 | Broadrick Dale |
10% Owner |
Buy↑
|
Common Stock
|
36,374 |
| 2023-12-01 | Broadrick Dale |
10% Owner |
Sell↓
|
Common Stock
|
250 |
| 2023-11-27 | Broadrick Dale |
10% Owner |
Sell↓
|
Common Stock
|
278 |
| 2023-09-15 | ALSTODT LANCE |
Director, President, CEO, COB, 10% Owner |
Buy↑
Filing footnotes — Common Stock (Direct)
This transaction was executed in multiple trades at prices ranging from $1.66 to $1.75 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected. Includes 48,912 shares received pursuant to an unvested restricted stock unit grant. Such shares vest on March 18, 2024. |
Common Stock
|
2,200 |
| 2023-09-15 | Broadrick Dale |
10% Owner |
Buy↑
|
Common Stock
|
10,000 |
| 2023-09-14 | Broadrick Dale |
10% Owner |
Buy↑
|
Common Stock
|
10,000 |
| 2023-09-13 | ALSTODT LANCE |
Director, President, CEO, COB, 10% Owner |
Buy↑
Filing footnotes — Common Stock (Direct)
This transaction was executed in multiple trades at prices ranging from $1.52 to $1.54 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected. Includes 48,912 shares received pursuant to an unvested restricted stock unit grant. Such shares vest on March 18, 2024. |
Common Stock
|
800 |
| 2023-09-07 | Broadrick Dale |
10% Owner |
Buy↑
Filing footnotes — Common Stock (Indirect)
Owned by Fleetco, Inc. of which the reporting person is a 93% shareholder. |
Common Stock
(I)
|
1,000 |
| 2023-09-07 | Broadrick Dale |
10% Owner |
Buy↑
|
Common Stock
|
1,000 |
| 2023-09-06 | ALSTODT LANCE |
Director, President, CEO, COB, 10% Owner |
Buy↑
Filing footnotes — Common Stock (Direct)
This transaction was executed in multiple trades at prices ranging from $1.93 to $2.02 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected. Includes 48,912 shares received pursuant to an unvested restricted stock unit grant. Such shares vest on March 18, 2024. |
Common Stock
|
2,887 |
| 2023-08-31 | Silva Francisco |
Director, VP of Research and Development |
Buy↑
Filing footnotes — Common Stock (Direct)
Includes 48,912 shares received pursuant to an unvested restricted stock unit grant. Such shares vest on March 18, 2024. |
Common Stock
|
4,954 |
| 2023-07-28 | Broadrick Dale |
10% Owner |
Buy↑
|
Common Stock
|
500 |
| 2023-07-27 | Broadrick Dale |
10% Owner |
Buy↑
Filing footnotes — Common Stock (Direct)
This transaction was executed in multiple trades at prices ranging from $2.75 to $2.85 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected. The reporting person also owns 316,972 shares indirectly through Fleetco, Inc. of which the reporting person is a 93% shareholder. |
Common Stock
|
1,000 |
| 2023-07-25 | ALSTODT LANCE |
Director, President, CEO, COB, 10% Owner |
Buy↑
Filing footnotes — Common Stock (Direct)
This transaction was executed in multiple trades at prices ranging from $2.41 to $2.47 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected. Includes 48,912 shares received pursuant to an unvested restricted stock unit grant. Such shares vest on March 18, 2024. |
Common Stock
|
4,200 |
| 2023-03-31 | Silva Francisco |
Director, VP of Research and Development |
Buy↑
Filing footnotes — Common Stock (Direct)
Includes 48,912 shares received pursuant to an unvested restricted stock unit grant. Such shares vest on March 18, 2024. |
Common Stock
|
747 |
| 2023-03-20 | Silva Francisco |
Director, VP of Research and Development |
Tax↓
Filing footnotes — Common Stock (Direct)
Shares were withheld from vested stock grant to pay the associated withholding taxes. Includes 48,912 shares received pursuant to an unvested restricted stock unit grant. Such shares vest on March 18, 2024. |
Common Stock
|
6,729 |
| 2023-03-20 | ALSTODT LANCE |
Director, President, CEO, COB, 10% Owner |
Tax↓
Filing footnotes — Common Stock (Direct)
Shares were withheld from vested stock grant to pay the associated withholding taxes. Includes 48,912 shares received pursuant to an unvested restricted stock unit grant. Such shares vest on March 18, 2024. |
Common Stock
|
6,729 |
| 2023-02-22 | Broadrick Dale |
10% Owner |
Buy↑
|
Common Stock
|
5,000 |
| 2023-02-22 | Broadrick Dale |
10% Owner |
Buy↑
|
Common Stock
|
1,000 |
| 2023-02-18 | Silva Francisco |
Director, VP of Research and Development |
Tax↓
Filing footnotes — Common Stock (Direct)
Shares were withheld from vested stock grant to pay the associated withholding taxes. Includes 98,862 shares received pursuant to an unvested restricted stock unit grant. Such shares vest to the extent of 49,949 shares on March 18, 2023 and 48,913 shares on March 18, 2024. |
Common Stock
|
374 |